UA81676C2 - Композиция для лечения инфекций у крупного рогатого скота и свиней - Google Patents

Композиция для лечения инфекций у крупного рогатого скота и свиней

Info

Publication number
UA81676C2
UA81676C2 UAA200512427A UAA200512427A UA81676C2 UA 81676 C2 UA81676 C2 UA 81676C2 UA A200512427 A UAA200512427 A UA A200512427A UA A200512427 A UAA200512427 A UA A200512427A UA 81676 C2 UA81676 C2 UA 81676C2
Authority
UA
Ukraine
Prior art keywords
swine
compositionss
cattle
treating infection
formulations
Prior art date
Application number
UAA200512427A
Other languages
English (en)
Ukrainian (uk)
Inventor
Кейт А. Фрихауф
Аллан Дж. Уэйнгартен
Кенвал Дж. Варма
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of UA81676C2 publication Critical patent/UA81676C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Композиции, которые содержат фторированную производную антибиотика хлорамфеникола или тиамфеникола, такую как флорфеникол, и способы применения таких композиций для лечения и предупреждения инфекционных заболеваний крупного рогатого скота и свиней, включая респираторное заболевание крупного рогатого скота.
UAA200512427A 2003-05-29 2004-05-28 Композиция для лечения инфекций у крупного рогатого скота и свиней UA81676C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47429403P 2003-05-29 2003-05-29
PCT/US2004/016841 WO2004110494A1 (en) 2003-05-29 2004-05-28 Compositions for treating infection in cattle and swine

Publications (1)

Publication Number Publication Date
UA81676C2 true UA81676C2 (ru) 2008-01-25

Family

ID=33551488

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200512427A UA81676C2 (ru) 2003-05-29 2004-05-28 Композиция для лечения инфекций у крупного рогатого скота и свиней

Country Status (24)

Country Link
US (2) US8034845B2 (ru)
EP (1) EP1626739B1 (ru)
JP (2) JP4728244B2 (ru)
KR (1) KR101132079B1 (ru)
CN (2) CN1795013A (ru)
AR (2) AR044437A1 (ru)
AU (2) AU2004247053B2 (ru)
BR (1) BRPI0410795B1 (ru)
CA (1) CA2526202C (ru)
CL (1) CL2004001293A1 (ru)
EC (1) ECSP056189A (ru)
ES (1) ES2492537T3 (ru)
IL (1) IL172224A0 (ru)
MX (1) MXPA05012827A (ru)
MY (1) MY146351A (ru)
NO (1) NO20056223L (ru)
NZ (1) NZ543594A (ru)
PE (1) PE20050386A1 (ru)
PL (2) PL1626739T3 (ru)
RU (1) RU2359659C2 (ru)
TW (1) TW200505425A (ru)
UA (1) UA81676C2 (ru)
WO (1) WO2004110494A1 (ru)
ZA (1) ZA200509544B (ru)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11090444B2 (en) 2018-06-15 2021-08-17 James T. Doubet Syringe adapter for medication
US10709850B2 (en) 2018-06-15 2020-07-14 James T. Doubet Syringe adapter for medication
US11337894B2 (en) 2018-06-15 2022-05-24 James T. Doubet Syringe adapter for animal medication
US11097058B2 (en) 2018-06-15 2021-08-24 James T. Doubet Syringe adapter for medication
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US6790867B2 (en) * 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
UA82359C2 (ru) * 2003-04-03 2008-04-10 Schering Plough Ltd Композиция (варианты) и способ лечения микробных и паразитарных инфекций у крупного рогатого скота и других животных
AR044437A1 (es) 2003-05-29 2005-09-14 Schering Plough Ltd Composiciones y metodo para el tratamiento de infecciones en ganado vacuno y porcino
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
ATE411046T1 (de) * 2004-12-21 2008-10-15 Intervet Int Bv Injizierbare veterinärmedizinische zusammensetzung enthaltend florfenicol
GB0501220D0 (en) * 2005-01-21 2005-03-02 Norbrook Lab Ltd Anthelmintic composition
CN101535238A (zh) * 2006-11-01 2009-09-16 普罗诺瓦生物医药挪威公司 作为过氧化物酶体增生物激活受体(PPAR)的活化剂或调节剂的α-取代的ω-3脂质
KR101544584B1 (ko) * 2006-11-01 2015-08-13 프로노바 바이오파마 너지 에이에스 오메가-3 지질 화합물
US8044230B2 (en) * 2006-12-13 2011-10-25 Intervet Inc. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
BRPI0720492A2 (pt) * 2006-12-19 2014-02-04 Schering Plough Ltd Formulações efervescentes de florfenicol para adição em sistemas de água potável
PE20091171A1 (es) * 2007-12-14 2009-08-03 Schering Plough Ltd Proceso para recuperar florfenicol y analogos de florfenicol
FR2925334A1 (fr) * 2007-12-21 2009-06-26 Ceva Sante Animale Sa Nouvelles compositions antibacteriennes
EP2321269B1 (en) * 2008-07-30 2018-09-19 Intervet International B.V. Process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol
DK2488145T3 (da) 2009-10-12 2024-07-22 Boehringer Ingelheim Vetmedica Gmbh Beholdere til sammensætninger omfattende meloxicam
KR101140167B1 (ko) * 2009-11-04 2012-04-24 최기동 동물용 의약 조성물 및 이를 포함하는 동물용 의약품
BRPI1002021A2 (pt) 2010-01-21 2012-05-22 Nanocore Biotecnologia S A composições farmacêuticas para tratamento de infecções bacterianas
BRPI1002023A2 (pt) 2010-03-01 2011-10-25 Nanocore Biotecnologia S A forma farmacêutica sólida de dissolução rápida para tratamento de infecções bacterianas
MX2012010077A (es) 2010-03-03 2012-09-12 Boehringer Ingelheim Vetmed Uso de meloxicam para el tratamiento a largo plazo de trastornos musculoesqueleticos en gatos.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
EP2654785B1 (en) * 2010-12-22 2019-03-20 Bayer Intellectual Property GmbH Enhanced immune response in bovine species
EA028412B9 (ru) * 2014-08-08 2018-03-30 Александр Петрович Мерабишвили Фармацевтический препарат ветеринарного назначения
EA028381B1 (ru) * 2014-08-08 2017-11-30 Александр Петрович Мерабишвили Фармацевтический препарат ветеринарного назначения
RU2563826C1 (ru) * 2014-08-21 2015-09-20 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Инъекционная антибактериальная фармацевтическая композиция
US20190233825A1 (en) * 2015-06-26 2019-08-01 Bayer Animal Health Gmbh Methods of modulating cytosolic dna surveillance molecules
US10463656B2 (en) * 2017-01-05 2019-11-05 Iowa State University Research Foundation, Inc. Methods and compositions for prevention of feedlot bovine respiratory disease
USD890925S1 (en) 2018-06-15 2020-07-21 James T. Doubet Syringe adapter for medication
US20190388625A1 (en) 2018-06-15 2019-12-26 James T. Doubet Syringe adapter for medication
BR112020026664A2 (pt) * 2018-06-25 2021-03-30 Intervet International B.V. Compostos úteis para o tratamento de infecção por mannheimia haemolytica ou histophilus somni

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2671748A (en) * 1950-05-18 1954-03-09 Parke Davis & Co Composition of matter
ES8104203A1 (es) * 1979-02-05 1981-04-16 Schering Corp Un procedimiento para la preparacion de un compuesto d-(treo-1-aril-2-acilamido-3-fluor-1-propanol
US4235892A (en) * 1979-02-05 1980-11-25 Schering Corporation, Patent Dept. 1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful therefor
US5105009A (en) 1983-06-02 1992-04-14 Zambon S.P.A. Intermediates for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoropropane derivatives
NZ234802A (en) * 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
US5663361A (en) 1996-08-19 1997-09-02 Schering Corporation Process for preparing intermediates to florfenicol
EP0949905B1 (en) * 1996-12-20 2001-07-18 Alza Corporation Injectable depot gel composition and method of preparing the composition
HUP0002125A3 (en) 1997-05-06 2001-01-29 Norbrook Lab Ltd Newry Improvements in or relating to long-acting antimicrobials
CA2211949A1 (en) * 1997-07-21 1999-01-29 David Farley Johnson Nonaqueous compositions for parenteral administration
JP2003512290A (ja) 1997-09-10 2003-04-02 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての８ａ−アザライド
BR9815352A (pt) * 1997-12-03 2000-10-17 Merck & Co Inc "formulação injetável de longa ação, e, processos para a prevenção ou tratamento de infestação parasìtica em um hospedeiro em necessidade dele, para tratamento ou prevenção de infestação por insetos por um perìodo prolongado de tempo em um hospedeiro em necessidade dele, para promover crescimento em animais, e para tratar inflamação, dor ou febre por um perìodo estendido de tempo em um hospedeiro em necessidade. "
ES2359973T3 (es) * 1998-03-19 2011-05-30 MERCK SHARP &amp; DOHME CORP. Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas.
US6136838A (en) 1998-03-19 2000-10-24 Merck & Co., Inc. Sulfurpentafluorophenylpyrazoles for controlling ectoparasitic infestations
US6174540B1 (en) * 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
JP2001226257A (ja) * 2000-02-17 2001-08-21 Material Eng Tech Lab Inc 溶液製剤
US6787568B1 (en) 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
CA2428993C (en) * 2000-11-29 2011-05-31 Lyotropic Therapeutics, Inc. Solvent systems for pharmaceutical agents
BR0308289A (pt) 2002-03-08 2005-01-11 Schering Plough Ltd Antibióticos do tipo florfenicol
US6790867B2 (en) * 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
CN1507858A (zh) 2002-12-19 2004-06-30 王玉万 含氟化氯霉素的兽用液体制剂
UA82359C2 (ru) * 2003-04-03 2008-04-10 Schering Plough Ltd Композиция (варианты) и способ лечения микробных и паразитарных инфекций у крупного рогатого скота и других животных
AR044437A1 (es) 2003-05-29 2005-09-14 Schering Plough Ltd Composiciones y metodo para el tratamiento de infecciones en ganado vacuno y porcino
US7781421B2 (en) * 2003-05-29 2010-08-24 Washington University Neuroactive 13, 24-cyclo-18, 21-dinorcholanes and structurally related pentacyclic steriods
BRPI0418133A2 (pt) 2003-12-23 2009-03-24 Schering Plough Ltd pró-fármaco de florfenicol tendo solubilidade em água melhorada
WO2005066119A2 (en) 2003-12-31 2005-07-21 Schering-Plough Ltd. Antibacterial 1-(4-mono-and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoropropanols and preparation thereof
ATE411046T1 (de) 2004-12-21 2008-10-15 Intervet Int Bv Injizierbare veterinärmedizinische zusammensetzung enthaltend florfenicol
EP1934189A2 (en) 2005-09-07 2008-06-25 Schering-Plough Ltd. A process for preparing oxazolidine protected aminodiol compounds useful as intermediates to florfenicol
US8119667B2 (en) 2005-12-29 2012-02-21 Schering-Plough Animal Health Corporation Carbonates of fenicol antibiotics
US8044230B2 (en) 2006-12-13 2011-10-25 Intervet Inc. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
EP2091909A1 (en) 2006-12-13 2009-08-26 Schering-Plough Ltd. Water-soluble prodrugs of florfenicol and its analogs
US20080153906A1 (en) 2006-12-13 2008-06-26 Celly Chander S Water-Soluble Phenicol Prodrugs in a Lipophilic Vehicle System
BRPI0720492A2 (pt) 2006-12-19 2014-02-04 Schering Plough Ltd Formulações efervescentes de florfenicol para adição em sistemas de água potável
KR20100028537A (ko) 2007-04-27 2010-03-12 쉐링-프라우 리미티드 사이클로덱스트린을 사용하여 플로르페니콜 및 구조적으로 관련된 항생제의 용해도를 증진시키기 위한 화합물 및 방법
CA2688432A1 (en) 2007-05-30 2008-12-11 Schering-Plough Ltd. A process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol
US20100210851A1 (en) 2007-07-25 2010-08-19 Towson James C Process for preparing oxazolidine- and oxazolidinone-aminodiols
KR20100085162A (ko) 2007-11-09 2010-07-28 인터벳 인터내셔널 비.브이. 속방성 고체 제형, 제조 및 이의 용도
PE20091171A1 (es) 2007-12-14 2009-08-03 Schering Plough Ltd Proceso para recuperar florfenicol y analogos de florfenicol

Also Published As

Publication number Publication date
CN102342925A (zh) 2012-02-08
WO2004110494A1 (en) 2004-12-23
CL2004001293A1 (es) 2005-05-06
US9084719B2 (en) 2015-07-21
ZA200509544B (en) 2007-01-31
EP1626739B1 (en) 2014-05-21
PE20050386A1 (es) 2005-06-23
MY146351A (en) 2012-08-15
AR101380A2 (es) 2016-12-14
PL380481A1 (pl) 2007-02-05
NZ543594A (en) 2010-03-26
CA2526202A1 (en) 2004-12-23
ECSP056189A (es) 2006-08-30
AR044437A1 (es) 2005-09-14
CA2526202C (en) 2012-07-03
CN1795013A (zh) 2006-06-28
KR20060016093A (ko) 2006-02-21
PL1626739T3 (pl) 2014-10-31
AU2010235885A1 (en) 2010-11-11
US8034845B2 (en) 2011-10-11
BRPI0410795B1 (pt) 2017-12-19
TW200505425A (en) 2005-02-16
ES2492537T3 (es) 2014-09-09
RU2005141127A (ru) 2006-06-10
IL172224A0 (en) 2009-02-11
AU2004247053A1 (en) 2004-12-23
NO20056223L (no) 2005-12-29
KR101132079B1 (ko) 2012-04-20
JP4728244B2 (ja) 2011-07-20
BRPI0410795A (pt) 2006-06-20
US20040242546A1 (en) 2004-12-02
EP1626739A1 (en) 2006-02-22
JP2006528705A (ja) 2006-12-21
RU2359659C2 (ru) 2009-06-27
MXPA05012827A (es) 2006-02-13
AU2004247053B2 (en) 2010-11-11
JP2007269801A (ja) 2007-10-18
US20120077764A1 (en) 2012-03-29

Similar Documents

Publication Publication Date Title
UA81676C2 (ru) Композиция для лечения инфекций у крупного рогатого скота и свиней
UA81629C2 (ru) Применение композиции и способ лечения инфекционных заболеваний крупного рогатого скота и свиней
CY1120977T1 (el) Θεραπεια των ασθενειων αποθηκευσης γλυκογονου τυπου ιι
BR0115531A (pt) Tratamento de mucosites
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
ECSP056074A (es) Composiciones y método para tratar las infecciones microbianas y parasitarias en el ganado y otros animales
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
BR0212898A (pt) Método de tratamento de infecções do ouvido médio
EA200601837A1 (ru) Бензоксазины для лечения заболеваний дыхательных путей
NO20044530L (no) Fremgangsmate for behandling av kognitive forstyrrelser
HUP0003845A2 (hu) Antimikrobiális 8a-azalidok alkalmazása
MXPA05004121A (es) Metodos para tratar la enfermedad de ojo reseco con lantibioticos.
MXPA05013703A (es) Aivlosin para el tratamiento de una enfermedad causada por brachyspira pilosicoli u ornithobacterium rhinotracheale.
BRPI0410576A (pt) composto quìmico, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, método para o tratamento, prevenção ou alìvio de uma doença ou um distúrbio ou condição de um corpo de animal vivo
GB2377638B (en) Treatment of infection in animals
EP1572089A4 (en) PROCESS FOR THE GROWTH OF HUMAN ORGANS, FOR THE TREATMENT OF DISEASES AND FOR EXTENDING LIFE
EP1578353A4 (en) METHODS OF USE AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF INFECTION DISEASES
DE60222528D1 (de) Impfstoff gegen Pferdearteritisvirus
TW200519078A (en) 2-alkylidene-19-nor-vitamin d derivatives for the treatment of a second hip fracture
UA37648A (uk) Спосіб лікування респіраторних захворювань у телят